• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴恶性肿瘤中糖皮质激素受体的共调节因子分析

Coregulator profiling of the glucocorticoid receptor in lymphoid malignancies.

作者信息

Clarisse Dorien, Thommis Jonathan, Van Wesemael Karlien, Houtman René, Ratman Dariusz, Tavernier Jan, Offner Fritz, Beck Ilse, De Bosscher Karolien

机构信息

Receptor Research Laboratories, Nuclear Receptor Lab (NRL) and Cytokine Receptor Lab (CRL), VIB-UGent Center for Medical Biotechnology, Ghent University, Ghent, Belgium.

Laboratory of Experimental Cancer Research (LECR), Department of Radiation Oncology and Experimental Cancer Research, Ghent University, Ghent, Belgium.

出版信息

Oncotarget. 2017 Nov 30;8(65):109675-109691. doi: 10.18632/oncotarget.22764. eCollection 2017 Dec 12.

DOI:10.18632/oncotarget.22764
PMID:29312638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5752551/
Abstract

Coregulators cooperate with nuclear receptors, such as the glucocorticoid receptor (GR), to enhance or repress transcription. These regulatory proteins are implicated in cancer, yet, their role in lymphoid malignancies, including multiple myeloma (MM) and acute lymphoblastic leukemia (ALL), is largely unknown. Here, we report the use and extension of the microarray assay for real-time nuclear receptor coregulator interactions (MARCoNI) technology to detect coregulator associations with endogenous GR in cell lysates. We use MARCoNI to determine the GR coregulator profile of glucocorticoid-sensitive (MM and ALL) and glucocorticoid-resistant (ALL) cells, and identify common and unique coregulators for different cell line comparisons. Overall, we identify SRC-1/2/3, PGC-1α, RIP140 and DAX-1 as the strongest interacting coregulators of GR in MM and ALL cells and show that the interaction strength does not correlate with GR protein levels. Lastly, as a step towards patient samples, we determine the GR coregulator profile of peripheral blood mononuclear cells. We profile the interactions between GR and coregulators in MM and ALL cells and suggest to further explore the GR coregulator profile in hematological patient samples.

摘要

共调节因子与核受体(如糖皮质激素受体(GR))协同作用,以增强或抑制转录。这些调节蛋白与癌症有关,然而,它们在包括多发性骨髓瘤(MM)和急性淋巴细胞白血病(ALL)在内的淋巴系统恶性肿瘤中的作用在很大程度上尚不清楚。在这里,我们报告了用于实时核受体共调节因子相互作用(MARCoNI)技术的微阵列分析方法的应用和扩展,以检测细胞裂解物中与内源性GR相关的共调节因子。我们使用MARCoNI来确定糖皮质激素敏感(MM和ALL)和糖皮质激素耐药(ALL)细胞的GR共调节因子谱,并识别不同细胞系比较中的共同和独特的共调节因子。总体而言,我们确定SRC-1/2/3、PGC-1α、RIP140和DAX-1是MM和ALL细胞中GR最强的相互作用共调节因子,并表明相互作用强度与GR蛋白水平无关。最后,作为迈向患者样本研究的一步,我们确定了外周血单个核细胞的GR共调节因子谱。我们分析了MM和ALL细胞中GR与共调节因子之间的相互作用,并建议进一步探索血液学患者样本中的GR共调节因子谱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7187/5752551/9d3fcdf7a1f2/oncotarget-08-109675-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7187/5752551/93aa9e4e62a7/oncotarget-08-109675-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7187/5752551/c7d34fc34e6f/oncotarget-08-109675-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7187/5752551/9d3fcdf7a1f2/oncotarget-08-109675-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7187/5752551/93aa9e4e62a7/oncotarget-08-109675-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7187/5752551/c7d34fc34e6f/oncotarget-08-109675-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7187/5752551/9d3fcdf7a1f2/oncotarget-08-109675-g005.jpg

相似文献

1
Coregulator profiling of the glucocorticoid receptor in lymphoid malignancies.淋巴恶性肿瘤中糖皮质激素受体的共调节因子分析
Oncotarget. 2017 Nov 30;8(65):109675-109691. doi: 10.18632/oncotarget.22764. eCollection 2017 Dec 12.
2
Distinct, genome-wide, gene-specific selectivity patterns of four glucocorticoid receptor coregulators.四种糖皮质激素受体共调节因子独特的全基因组、基因特异性选择性模式。
Nucl Recept Signal. 2014 Nov 4;12:e002. doi: 10.1621/nrs.12002. eCollection 2014.
3
Cofactor profiling of the glucocorticoid receptor from a cellular environment.细胞环境中糖皮质激素受体的辅助因子分析
Methods Mol Biol. 2014;1204:83-94. doi: 10.1007/978-1-4939-1346-6_8.
4
A Model of Glucocorticoid Receptor Interaction With Coregulators Predicts Transcriptional Regulation of Target Genes.糖皮质激素受体与共调节因子相互作用的模型预测靶基因的转录调控。
Front Pharmacol. 2019 Mar 13;10:214. doi: 10.3389/fphar.2019.00214. eCollection 2019.
5
Mechanisms of Glucocorticoid-Regulated Gene Transcription.糖皮质激素调节基因转录的机制
Adv Exp Med Biol. 2015;872:59-81. doi: 10.1007/978-1-4939-2895-8_3.
6
[P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].[P38丝裂原活化蛋白激酶介导地塞米松诱导的急性淋巴细胞白血病细胞中的糖皮质激素受体功能]
Zhonghua Er Ke Za Zhi. 2007 Sep;45(9):687-91.
7
Corticosteroid Action in the Brain: The Potential of Selective Receptor Modulation.皮质甾类激素在大脑中的作用:选择性受体调节的潜力。
Neuroendocrinology. 2019;109(3):266-276. doi: 10.1159/000499659. Epub 2019 Mar 19.
8
Changes of glucocorticoid receptor isoforms expression in acute lymphoblastic leukemia correlate with glucocorticoid resistance.急性淋巴细胞白血病中糖皮质激素受体亚型表达的变化与糖皮质激素抵抗相关。
Pharmazie. 2015 May;70(5):316-21.
9
Optical probes to identify the glucocorticoid receptor ligands in living cells.用于识别活细胞中糖皮质激素受体配体的光学探针。
Steroids. 2007 Dec;72(14):949-54. doi: 10.1016/j.steroids.2007.08.006. Epub 2007 Aug 22.
10
Nuclear receptor coregulators differentially modulate induction and glucocorticoid receptor-mediated repression of the corticotropin-releasing hormone gene.核受体共调节因子对促肾上腺皮质激素释放激素基因的诱导及糖皮质激素受体介导的抑制具有不同的调节作用。
Endocrinology. 2008 Feb;149(2):725-32. doi: 10.1210/en.2007-1234. Epub 2007 Nov 15.

引用本文的文献

1
Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries.糖皮质激素、作用、性别二态性与疾病:新概念、新机制与新发现。
Physiol Rev. 2024 Jan 1;104(1):473-532. doi: 10.1152/physrev.00021.2023. Epub 2023 Sep 21.
2
Modulating glucocorticoid receptor actions in physiology and pathology: Insights from coregulators.调节糖皮质激素受体在生理和病理中的作用:共激活因子的见解。
Pharmacol Ther. 2023 Nov;251:108531. doi: 10.1016/j.pharmthera.2023.108531. Epub 2023 Sep 16.
3
Crosstalk between glucocorticoid and mineralocorticoid receptors boosts glucocorticoid-induced killing of multiple myeloma cells.

本文引用的文献

1
Compound A influences gene regulation of the Dexamethasone-activated glucocorticoid receptor by alternative cofactor recruitment.化合物 A 通过招募替代辅助因子影响地塞米松激活的糖皮质激素受体的基因调控。
Sci Rep. 2017 Aug 14;7(1):8063. doi: 10.1038/s41598-017-07941-y.
2
Anti-Inflammatory Chromatinscape Suggests Alternative Mechanisms of Glucocorticoid Receptor Action.抗炎染色质景观提示糖皮质激素受体作用的替代机制。
Immunity. 2017 Aug 15;47(2):298-309.e5. doi: 10.1016/j.immuni.2017.07.012. Epub 2017 Aug 8.
3
Glucocorticoid receptors: finding the middle ground.
糖皮质激素受体和盐皮质激素受体之间的串扰增强了糖皮质激素诱导的多发性骨髓瘤细胞的杀伤作用。
Cell Mol Life Sci. 2023 Aug 14;80(9):249. doi: 10.1007/s00018-023-04900-x.
4
Structures of human TR4LBD-JAZF1 and TR4DBD-DNA complexes reveal the molecular basis of transcriptional regulation.人源 TR4LBD-JAZF1 和 TR4DBD-DNA 复合物结构揭示了转录调控的分子基础。
Nucleic Acids Res. 2023 Feb 22;51(3):1443-1457. doi: 10.1093/nar/gkac1259.
5
Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer.糖皮质激素受体触发肺癌中具有获得性治疗脆弱性的可逆性耐药休眠状态。
Nat Commun. 2021 Jul 16;12(1):4360. doi: 10.1038/s41467-021-24537-3.
6
SUMOylation regulates the protein network and chromatin accessibility at glucocorticoid receptor-binding sites.SUMOylation 调节糖皮质激素受体结合位点的蛋白质网络和染色质可及性。
Nucleic Acids Res. 2021 Feb 26;49(4):1951-1971. doi: 10.1093/nar/gkab032.
7
Fighting the Fire: Mechanisms of Inflammatory Gene Regulation by the Glucocorticoid Receptor.抗击炎症:糖皮质激素受体调节炎症基因的机制。
Front Immunol. 2019 Aug 7;10:1859. doi: 10.3389/fimmu.2019.01859. eCollection 2019.
8
The future of myeloma precision medicine: integrating the compendium of known drug resistance mechanisms with emerging tumor profiling technologies.多发性骨髓瘤精准医学的未来:将已知耐药机制纲要与新兴肿瘤分析技术相结合。
Leukemia. 2019 Apr;33(4):863-883. doi: 10.1038/s41375-018-0362-z. Epub 2019 Jan 25.
9
Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies.联合糖皮质激素与化合物 A 对淋巴恶性肿瘤中糖皮质激素受体反应性的影响。
PLoS One. 2018 May 8;13(5):e0197000. doi: 10.1371/journal.pone.0197000. eCollection 2018.
糖皮质激素受体:寻找中间立场。
J Clin Invest. 2017 Apr 3;127(4):1136-1145. doi: 10.1172/JCI88886. Epub 2017 Mar 20.
4
Targeting Class I Histone Deacetylases in a "Complex" Environment.靶向“复杂”环境中的 I 类组蛋白去乙酰化酶。
Trends Pharmacol Sci. 2017 Apr;38(4):363-377. doi: 10.1016/j.tips.2016.12.006. Epub 2017 Jan 28.
5
Glucocorticoid receptor control of transcription: precision and plasticity via allostery.糖皮质激素受体对转录的调控:通过变构实现的精确性和可塑性
Nat Rev Mol Cell Biol. 2017 Mar;18(3):159-174. doi: 10.1038/nrm.2016.152. Epub 2017 Jan 5.
6
Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments.癌症治疗中的选择性糖皮质激素受体激活辅助疗法。
Oncoscience. 2016 Jul 27;3(7-8):188-202. doi: 10.18632/oncoscience.315. eCollection 2016.
7
Molecular Pathways: Targeting Steroid Receptor Coactivators in Cancer.分子途径:在癌症中靶向类固醇受体共激活因子
Clin Cancer Res. 2016 Nov 15;22(22):5403-5407. doi: 10.1158/1078-0432.CCR-15-1958. Epub 2016 Sep 21.
8
Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management.多发性骨髓瘤:2016年诊断、风险分层及管理的最新进展
Am J Hematol. 2016 Jul;91(7):719-34. doi: 10.1002/ajh.24402.
9
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma.组蛋白去乙酰化酶抑制剂在多发性骨髓瘤中的临床应用
Clin Pharmacol. 2016 May 6;8:35-44. doi: 10.2147/CPAA.S94021. eCollection 2016.
10
The Role of Steroid Receptor Coactivators in Hormone Dependent Cancers and Their Potential as Therapeutic Targets.类固醇受体共激活因子在激素依赖性癌症中的作用及其作为治疗靶点的潜力。
Horm Cancer. 2016 Aug;7(4):229-35. doi: 10.1007/s12672-016-0261-6. Epub 2016 Apr 28.